A new type of daily pill, orforglipron, has proven more effective for weight loss and blood sugar control than its current counterparts, according to a recent trial. The drug, known as semaglutide, is a class of glucagon-like peptide-1 (GLP-1) medication that mimics the gut hormone GLP1, which signals fullness to the brain, slows digestion and stimulates insulin release. However, the drug requires to be injected into the belly, thighs or back of the arm, which can make it difficult for patients with needle phobia or who don't want to self-inject. It also requires refrigeration throughout the supply chain. However a recent phase 3 clinical trial found that orforGlipron was more effective than current oral semagmutide products. The study also found that participants who took orforGLipron lost more weight and reduced HbA1c.